Brief: IGC Pharma Advances IGC-AD1 Toward Clinical Trials As A Potential Anti-Amyloid Plaque Treatment For Alzheimer's Disease

IGC Pharma

04/09/2024 13:13

Sept 4 (Reuters) - IGC Pharma Inc  IGC.A :
    * IGC PHARMA ADVANCES IGC-AD1 TOWARD CLINICAL TRIALS AS A
POTENTIAL ANTI-AMYLOID PLAQUE TREATMENT FOR ALZHEIMER'S DISEASE
    * IGC PHARMA INC: INITIATION OF DISEASE-MODIFYING
INVESTIGATIONAL
TRIALS, EXPECTED IN EARLY 2025

Source text for Eikon:  ID:nBw3xDVPCa 
Further company coverage:  IGC.A 

 ((Reuters.Brief@thomsonreuters.com;))